查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2041536

全球分子診斷市場規模、佔有率、趨勢和成長分析報告（2026-2034）

Global Molecular Diagnostics Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 176 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

全球分子診斷市場預計將從2025年的155.3億美元成長至2034年的302.1億美元，2026年至2034年的複合年成長率（CAGR）為7.67%。該市場正經歷快速成長，主要得益於精準早期疾病檢測需求的不斷成長。分子診斷技術能夠識別遺傳和分子標記，在感染疾病、癌症和遺傳性疾病的診斷中發揮至關重要的作用。對個人化和精準醫療的日益重視也顯著推動了市場擴張。

關鍵促進因素包括基因組學的進步、慢性病盛行率的上升以及就地檢驗解決方案的日益普及。醫療服務提供者正在投資先進的診斷工具，以改善患者預後並降低治療成本。政府的研發計畫和資金投入也在推動市場成長。此外，自動化和數位技術的整合也提高了診斷效率。

分子診斷市場的未來前景仍然十分光明，持續的創新有望提升其準確性和可及性。次世代定序和生物標記發現技術的進步將徹底革新診斷領域。隨著醫療基礎設施的不斷完善，新興市場預計將帶來強勁的成長機會。總體而言，隨著對先進診斷解決方案的需求不斷成長，該市場預計將顯著擴張。

我們的報告經過精心撰寫，旨在提供涵蓋廣泛行業和市場的全面且切實可行的洞察。每份報告都包含幾個關鍵組成部分，旨在幫助您全面了解市場環境：

市場概覽：本節提供清晰的市場概覽，包括關鍵定義、分類和當前產業格局。

市場動態：對影響市場成長的主要促進因素、限制因素、機會和挑戰進行詳細評估。這包括技術發展、法律規範和不斷變化的行業趨勢等因素。

市場區隔分析：本部分依據產品類型、應用、最終使用者和地區，將市場系統性地分類為若干關鍵細分市場。本部分揭示了每個細分市場的表現、成長潛力和市場貢獻。

競爭格局：我們對主要市場參與企業的市場定位、產品系列、策略舉措和財務表現進行了詳細評估。這為了解競爭趨勢和主要參與者所採取的策略提供了寶貴的見解。

市場預測：本預測是基於特定預測期內的市場規模和成長模式數據。本節結合歷史趨勢、當前市場狀況和定量分析，揭示未來預期趨勢。

區域分析：本部分全面回顧了主要地理區域的市場表現，確定了高成長領域和區域趨勢，從而更深入地了解區域市場機會。

新趨勢與新機會：識別關鍵市場趨勢、技術進步和新興投資機會。本部分重點在於潛在成長領域和未來產業趨勢。

客製化選項：我們提供靈活的客製化服務，可根據您的具體需求自訂報告。這包括額外的細分、特定國家/地區的分析、競爭對手分析、客製化資料點，或針對特定細分市場的深入洞察，以更好地支援您的策略決策。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 滲透率和成長前景分析
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制因素
    • 市場機遇
    • 市場挑戰
  • 波特五力分析
  • PESTLE分析

第4章 全球分子診斷市場：依產品類型分類

  • 市場分析、洞察與預測
  • 裝置
  • 試劑和耗材

第5章 全球分子診斷市場：依應用分類

  • 市場分析、洞察與預測
  • 感染疾病
  • 血液篩檢
  • 組織學
  • 腫瘤學
  • 其他

第6章：全球分子診斷市場：依方法論分類

  • 市場分析、洞察與預測
  • 放大技術
  • 雜合反應技術
  • 定序技術
  • 其他

第7章 全球分子診斷市場：依最終用戶分類

  • 市場分析、洞察與預測
  • 醫院
  • 臨床和病理檢查室
  • 其他

第8章 全球分子診斷市場：依地區分類

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第9章 競爭情勢

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴（根據現有資訊）
  • 市場佔有率和市場定位分析（基於現有資訊）
  • 供應商情況（基於現有資訊）
  • 策略規劃

第10章：公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • BioMerieux SA
    • BD
    • Danaher Corporation
    • Grifols, SA
    • Hologic Inc
    • Novartis AG
    • QIAGEN
    • Siemens Healthcare GmbH
    • F. Hoffmann-La Roche Ltd
簡介目錄
Product Code: VMR11210463

The global molecular diagnostics market size is expected to reach USD 30.21 Billion in 2034 from USD 15.53 Billion in 2025, growing at a CAGR of 7.67 during 2026-2034.This market is witnessing rapid growth due to increasing demand for accurate and early disease detection. Molecular diagnostics technologies enable the identification of genetic and molecular markers, playing a critical role in diagnosing infectious diseases, cancer, and genetic disorders. The growing emphasis on personalized medicine and precision healthcare is significantly driving market expansion.

Key drivers include advancements in genomic technologies, increasing prevalence of chronic diseases, and rising adoption of point-of-care testing solutions. Healthcare providers are investing in advanced diagnostic tools to improve patient outcomes and reduce treatment costs. Government initiatives and funding for research and development are also supporting market growth. Additionally, the integration of automation and digital technologies is enhancing diagnostic efficiency.

The future outlook for the molecular diagnostics market remains highly promising, with continuous innovation expected to improve accuracy and accessibility. Developments in next-generation sequencing and biomarker discovery will revolutionize diagnostics. Emerging markets will offer strong growth opportunities due to improving healthcare infrastructure. Overall, the market is set to expand significantly as demand for advanced diagnostic solutions increases.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Product Type

  • Instruments
  • Reagents & Consumables

By Application

  • Infectious Disease
  • Blood Screening
  • Histology
  • Oncology
  • Others

By Technique

  • Amplification Techniques
  • Hybridization Techniques
  • Sequencing Techniques
  • Others

By End User

  • Hospitals
  • Clinical & Pathology Labs
  • Others

COMPANIES PROFILED

  • bioMerieux SA., BD, Danaher Corporation, Grifols, S.A., Hologic Inc., Novartis AG, QIAGEN, Siemens Healthcare GmbH, F. Hoffmann-La Roche Ltd.

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL MOLECULAR DIAGNOSTICS MARKET: BY PRODUCT TYPE 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Product Type
  • 4.2. Instruments Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Reagents & Consumables Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL MOLECULAR DIAGNOSTICS MARKET: BY APPLICATION 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Application
  • 5.2. Infectious Disease Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Blood Screening Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Histology Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.5. Oncology Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL MOLECULAR DIAGNOSTICS MARKET: BY TECHNIQUE 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast Technique
  • 6.2. Amplification Techniques Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Hybridization Techniques Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.4. Sequencing Techniques Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL MOLECULAR DIAGNOSTICS MARKET: BY END USER 2022-2034 (USD MN)

  • 7.1. Market Analysis, Insights and Forecast End User
  • 7.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.3. Clinical & Pathology Labs Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL MOLECULAR DIAGNOSTICS MARKET: BY REGION 2022-2034 (USD MN)

  • 8.1. Regional Outlook
  • 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.2.1 By Product Type
    • 8.2.2 By Application
    • 8.2.3 By Technique
    • 8.2.4 By End User
    • 8.2.5 United States
    • 8.2.6 Canada
    • 8.2.7 Mexico
  • 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.3.1 By Product Type
    • 8.3.2 By Application
    • 8.3.3 By Technique
    • 8.3.4 By End User
    • 8.3.5 United Kingdom
    • 8.3.6 France
    • 8.3.7 Germany
    • 8.3.8 Italy
    • 8.3.9 Russia
    • 8.3.10 Rest Of Europe
  • 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.4.1 By Product Type
    • 8.4.2 By Application
    • 8.4.3 By Technique
    • 8.4.4 By End User
    • 8.4.5 India
    • 8.4.6 Japan
    • 8.4.7 South Korea
    • 8.4.8 Australia
    • 8.4.9 South East Asia
    • 8.4.10 Rest Of Asia Pacific
  • 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.5.1 By Product Type
    • 8.5.2 By Application
    • 8.5.3 By Technique
    • 8.5.4 By End User
    • 8.5.5 Brazil
    • 8.5.6 Argentina
    • 8.5.7 Peru
    • 8.5.8 Chile
    • 8.5.9 Rest of Latin America
  • 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.6.1 By Product Type
    • 8.6.2 By Application
    • 8.6.3 By Technique
    • 8.6.4 By End User
    • 8.6.5 Saudi Arabia
    • 8.6.6 UAE
    • 8.6.7 Israel
    • 8.6.8 South Africa
    • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

  • 9.1. Recent Developments
  • 9.2. Company Categorization
  • 9.3. Supply Chain & Channel Partners (based on availability)
  • 9.4. Market Share & Positioning Analysis (based on availability)
  • 9.5. Vendor Landscape (based on availability)
  • 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL MOLECULAR DIAGNOSTICS INDUSTRY

  • 10.1. Top Companies Market Share Analysis
  • 10.2. Company Profiles
    • 10.2.1 BioMerieux SA
    • 10.2.2 BD
    • 10.2.3 Danaher Corporation
    • 10.2.4 Grifols, S.A
    • 10.2.5 Hologic Inc
    • 10.2.6 Novartis AG
    • 10.2.7 QIAGEN
    • 10.2.8 Siemens Healthcare GmbH
    • 10.2.9 F. Hoffmann-La Roche Ltd